person · Reporting owner
Graham Elizabeth Ames
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Starry Group Holdings, Inc.STRY · Entity 121827 | Director | March 28, 2022 | March 28, 2022 |
| iSpecimen Inc.ISPC · Entity 8372 | Director | March 21, 2024 | May 20, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Starry Group Holdings, Inc.
Report date March 28, 2022 · Filed March 28, 2022
This filing explicitly reported no securities owned.
iSpecimen Inc.
Report date March 21, 2024 · Filed May 20, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.28 · Expires 2034-03-20 | Direct | 8,340 |
Reported balance
After 2024-03-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-03-21 · Grant · Acquired 8,340 · Balance 8,340 F1: Represents stock options granted to the reporting person on March 21, 2024, pursuant to the Issuer's Amended and Restated Stock Incentive Plan. The stock options vest respect to 2,085 shares on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents stock options granted to the reporting person on March 21, 2024, pursuant to the Issuer's Amended and Restated Stock Incentive Plan. The stock options vest respect to 2,085 shares on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 21, 2024 Filed May 20, 2024 19:23 UTC | iSpecimen Inc. ISPC · Entity 8372 | GrantOption · Derivative | 8,340 | $0.28 Strike: $0.28 | $2,335.20 |
DisclosureSEC source: 0001104659-24-063359 · tm2414962-3_4seq1.xml · derivative · entry 1 Graham Elizabeth Ames · CIK 0001916581 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,340 Underlying: Common Stock · 8,340 shares Expires 2034-03-20 F1 · derivative.exercise_date: Represents stock options granted to the reporting person on March 21, 2024, pursuant to the Issuer's Amended and Restated Stock Incentive Plan. The stock options vest respect to 2,085 shares on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.